tradingkey.logo
tradingkey.logo
Search

NeuroOne Medical Technologies Corp

NMTC
Add to Watchlist
1.360USD
0.0000.00%
Market hours 09/18, 14:02ET
11.84MMarket Cap
LossP/E TTM

NMTC Financials

See NeuroOne Medical Technologies Corp's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Key Financial Ratios

Market Cap
11.84M
Dividend TTM
0.00
P/E TTM
-0.46
EPS TTM
-2.95
Revenue
12.10M
Net Profit
-12.32M
ROE
-204.44%
ROA
-107.84%

NeuroOne Medical Technologies Corp Earnings Date

Latest Release
Aug 13, 2026
EPS / Forecast
-0.23/-0.22
Revenue / Forecast
1.97M/2.55M

Financial Statement Highlights

Quarterly
Quarterly+Annual
Quarterly
Annual
FY2026Q3
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
Financial Indicators
EPS
-25.02%-0.23
43.86%-0.25
-149.35%-0.17
71.22%-0.03
69.48%-0.03
70.63%-0.07
141.53%0.06
20.18%-0.11
48.73%-0.10
-15.80%-0.25
-30.57%-0.14
---0.14
---0.20
---0.21
---0.11
---0.63
----
----
----
----
Revenue
16.34%1.97M
72.46%2.39M
-53.90%2.89M
906.64%2.74M
105.39%1.70M
0.67%1.39M
541.76%6.27M
-65.20%272.28K
31.10%825.78K
195.45%1.38M
-37.72%977.65K
-61.09%782.52K
1865.45%629.91K
1174.26%466.18K
3812.48%1.57M
3672.81%2.01M
-44.31%32.05K
-4.61%36.58K
-57.20%40.12K
-97.23%53.31K
Net Profit
-33.68%-2.01M
8.14%-2.09M
-180.54%-1.44M
51.67%-1.62M
45.77%-1.50M
20.47%-2.27M
153.37%1.79M
-6.87%-3.35M
20.22%-2.77M
18.95%-2.86M
-93.04%-3.34M
-128.12%-3.14M
-25.69%-3.47M
-15.20%-3.52M
38.28%-1.73M
48.00%-1.37M
6.50%-2.76M
-27.74%-3.06M
-43.28%-2.81M
-366.67%-2.64M
Net Margin
-14.91%-101.68%
46.74%-87.22%
-274.69%-49.71%
95.20%-59.08%
73.60%-88.49%
21.00%-163.76%
108.32%28.46%
-207.14%-1230.55%
39.14%-335.14%
72.57%-207.30%
-209.95%-342.14%
---400.65%
---550.68%
---755.69%
---110.38%
---471.67%
----
----
----
----
Gross Margin
11.12%59.94%
-3.24%53.81%
-30.98%54.20%
7.65%55.77%
58.02%53.94%
99.41%55.61%
188.27%78.53%
72.96%51.81%
-11.76%34.13%
312.67%27.89%
-70.36%27.24%
--29.95%
--38.68%
--6.76%
--91.92%
--88.59%
----
----
----
----
Debt to assets ratio
----
-70.45%9.02%
-65.11%9.41%
-70.53%11.75%
--9.62%
--30.53%
--26.96%
--39.86%
----
----
--0.00%
--0.00%
--0.00%
--0.00%
--0.00%
--0.00%
----
----
----
----
Revenue
16.34%1.97M
72.46%2.39M
-53.90%2.89M
906.64%2.74M
105.39%1.70M
0.67%1.39M
541.76%6.27M
-65.20%272.28K
31.10%825.78K
195.45%1.38M
-37.72%977.65K
-61.09%782.52K
1865.45%629.91K
1174.26%466.18K
3812.48%1.57M
3672.81%2.01M
-44.31%32.05K
-4.61%36.58K
-57.20%40.12K
-97.23%53.31K
Operating profit
-28.50%-2.42M
21.61%-2.10M
-199.77%-1.71M
51.32%-1.37M
32.47%-1.89M
7.14%-2.68M
150.47%1.71M
11.00%-2.82M
20.41%-2.79M
17.44%-2.89M
-90.01%-3.39M
-126.02%-3.16M
-27.12%-3.51M
-14.25%-3.50M
36.48%-1.78M
47.04%-1.40M
9.01%-2.76M
-27.72%-3.06M
-31.07%-2.81M
-2151.75%-2.64M
Net Profit
-33.68%-2.01M
8.14%-2.09M
-180.54%-1.44M
51.67%-1.62M
45.77%-1.50M
20.47%-2.27M
153.37%1.79M
-6.87%-3.35M
20.22%-2.77M
18.95%-2.86M
-93.04%-3.34M
-128.12%-3.14M
-25.69%-3.47M
-15.20%-3.52M
38.28%-1.73M
48.00%-1.37M
6.50%-2.76M
-27.74%-3.06M
-43.28%-2.81M
-366.67%-2.64M
Current assets
-43.08%5.79M
97.22%7.40M
41.24%8.07M
120.83%10.23M
148.95%10.17M
-20.29%3.75M
12.15%5.71M
-36.67%4.63M
-16.26%4.09M
-25.91%4.71M
-43.20%5.09M
-39.94%7.31M
-55.36%4.88M
-52.71%6.36M
-45.90%8.97M
66.97%12.18M
17.88%10.93M
18.38%13.44M
125.82%16.58M
75.50%7.29M
Total current liabilities
43.18%2.04M
-4.19%1.69M
-19.89%1.26M
4.06%2.30M
-15.68%1.43M
14.47%1.76M
13.57%1.57M
23.46%2.21M
-3.26%1.69M
-0.64%1.54M
3.63%1.38M
-42.15%1.79M
114.59%1.75M
91.35%1.55M
25.64%1.33M
162.22%3.10M
9.06%814.52K
7.98%810.23K
-82.82%1.06M
-49.84%1.18M
Total assets
-42.82%6.19M
76.48%7.86M
32.08%8.58M
100.85%10.79M
120.24%10.82M
-17.39%4.46M
11.54%6.49M
-33.68%5.37M
-14.68%4.91M
-25.12%5.39M
-39.73%5.82M
-36.85%8.10M
-50.24%5.76M
-48.86%7.21M
-43.78%9.66M
61.52%12.82M
17.96%11.57M
18.22%14.09M
117.15%17.18M
66.78%7.94M
Total liabilities
-8.46%2.42M
-25.20%2.49M
-38.87%2.18M
-18.36%3.71M
38.99%2.64M
116.22%3.33M
153.46%3.56M
146.11%4.55M
3.49%1.90M
-7.88%1.54M
-5.66%1.40M
-42.58%1.85M
92.85%1.84M
73.06%1.67M
20.46%1.49M
132.43%3.22M
-0.14%952.48K
-8.59%966.27K
-81.00%1.24M
-48.60%1.38M
Total equity
-53.93%3.77M
377.29%5.37M
118.10%6.40M
760.39%7.07M
171.52%8.18M
-70.79%1.13M
-33.56%2.94M
-86.85%822.01K
-23.20%3.01M
-30.33%3.85M
-45.93%4.42M
-34.93%6.25M
-63.07%3.92M
-57.84%5.53M
-48.76%8.17M
46.54%9.60M
19.91%10.62M
20.83%13.12M
1032.53%15.95M
217.20%6.55M
Net operating income
26.08%-1.08M
-2001.23%-1.33M
-3662.99%-3.12M
42.79%-1.53M
38.00%-1.46M
97.09%-63.23K
97.83%-82.80K
8.13%-2.67M
19.72%-2.36M
38.75%-2.18M
-9.08%-3.81M
-385.20%-2.90M
-11.52%-2.94M
-10.24%-3.55M
-30.35%-3.49M
150.16%1.02M
-15.17%-2.64M
-35.37%-3.22M
-40.69%-2.68M
-844.24%-2.03M
Net investment
54.86%-19.66K
-1114.63%-38.52K
-66.92%-40.75K
71.26%-10.61K
-194.22%-43.55K
89.89%-3.17K
34.24%-24.42K
26.37%-36.91K
-101.72%-14.80K
-101.72%-31.36K
-346.41%-37.13K
98.35%-50.12K
1687.03%860.71K
2054.91%1.82M
124.51%15.07K
-8546.56%-3.04M
-81.32%-54.23K
-4432.25%-93.32K
---61.49K
37.70%-35.11K
Net financing
-95.81%345.03K
141.62%609.62K
167.66%147.82K
-97.37%66.98K
427.16%8.23M
-87.13%252.31K
-118.13%-218.47K
-51.00%2.54M
-0.02%1.56M
196.12%1.96M
7768.90%1.21M
--5.19M
--1.56M
205677.95%661.96K
-100.13%-15.71K
100.00%0.00
-100.00%0.00
-100.00%-322.00
140.62%12.02M
-545.64%-24.98K

FAQs

What is the total revenue of NeuroOne Medical Technologies Corp?

According to NeuroOne Medical Technologies Corp's FY2025 earnings report, its total revenue reached 12.10M, with a year-on-year change of 3.45M.

What are the current assets of NeuroOne Medical Technologies Corp?

According to NeuroOne Medical Technologies Corp's FY2025 earnings report, its current assets were 10.23M, with a year-on-year change of 120.83.

What are the total assets of NeuroOne Medical Technologies Corp?

According to NeuroOne Medical Technologies Corp's FY2025 earnings report, its total assets of NeuroOne Medical Technologies Corp were 10.79M, with a year-on-year change of 100.85.

What are the total liabilities of NeuroOne Medical Technologies Corp?

According to NeuroOne Medical Technologies Corp's FY2025 earnings report, its total liabilities of NeuroOne Medical Technologies Corp were 3.71M, with a year-on-year change of -18.36.

What is the total equity of NeuroOne Medical Technologies Corp?

According to NeuroOne Medical Technologies Corp's FY2025 earnings report, its total equity of NeuroOne Medical Technologies Corp was 7.07M, with a year-on-year change of 760.39.

What is the net operating income of NeuroOne Medical Technologies Corp?

According to NeuroOne Medical Technologies Corp's FY2025 earnings report, its net operating income of NeuroOne Medical Technologies Corp was -4.23M, with a year-on-year change of 64.45.

What is the net investment of NeuroOne Medical Technologies Corp?

According to NeuroOne Medical Technologies Corp's FY2025 earnings report, its net investment of NeuroOne Medical Technologies Corp was -81.74K, with a year-on-year change of 31.99.

What is the net financing of NeuroOne Medical Technologies Corp?

According to NeuroOne Medical Technologies Corp's FY2025 earnings report, its net financing of NeuroOne Medical Technologies Corp was 8.33M, with a year-on-year change of 14.55.

What is the Earnings Per Share (EPS) of NeuroOne Medical Technologies Corp?

According to NeuroOne Medical Technologies Corp's FY2025 earnings report, its Earnings Per Share (EPS) was -0.54, with a year-on-year change of 80.49.

What is the net income of NeuroOne Medical Technologies Corp?

According to NeuroOne Medical Technologies Corp's FY2025 earnings report, its net income was -3.61M, with a year-on-year change of 70.73.

What is the net margin of NeuroOne Medical Technologies Corp?

According to NeuroOne Medical Technologies Corp's FY2025 earnings report, its net profit margin was -29.80, with a year-on-year change of 91.65.

What is the gross margin of NeuroOne Medical Technologies Corp?

According to NeuroOne Medical Technologies Corp's FY2025 earnings report, its gross margin was 67.30, with a year-on-year change of 115.23.

What is the debt-to-asset ratio of NeuroOne Medical Technologies Corp?

According to NeuroOne Medical Technologies Corp's FY2025 earnings report, its debt-to-asset ratio was 11.75, with a year-on-year change of -70.53.

What is the Return on Equity (ROE) of NeuroOne Medical Technologies Corp?

According to NeuroOne Medical Technologies Corp's FY2025 earnings report, its Return on Equity (ROE) was -91.34, with a year-on-year change of 73.78.

What is the Return on Assets (ROA) of NeuroOne Medical Technologies Corp?

According to NeuroOne Medical Technologies Corp's FY2025 earnings report, its Return on Assets (ROA) was -44.63, with a year-on-year change of 75.60.

What is the operating profit of NeuroOne Medical Technologies Corp?

According to NeuroOne Medical Technologies Corp's FY2025 earnings report, its operating profit was -4.23M, with a year-on-year change of 64.45.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.